Literature DB >> 10362751

Conditioned immunosuppression makes subtherapeutic cyclosporin effective via splenic innervation.

M S Exton1, M Schult, S Donath, T Strubel, U Bode, A del Rey, J Westermann, M Schedlowski.   

Abstract

The present study investigated the mechanisms by which conditioned immunosuppression enhances the effectiveness of cyclosporin A (CsA) treatment in prolonging heart allograft survival. Dark Agouti rats that were administered subtherapeutic CsA (7 x 2 mg/kg on alternate days) rejected heart allografts at the same time as non-CsA-treated rats. The addition of a behavioral conditioning regimen (conditioned stimulus, saccharin; unconditioned stimulus, 20 mg/kg CsA) to the subtherapeutic CsA protocol produced a significant prolongation of graft survival, including long-term survival (>100 days) in 20% of the animals. Prior sympathetic denervation of the spleen completely blocked this effect. In nontransplanted rats both conditioning and CsA treatment reduce interleukin-2 and interferon (IFN)-gamma in the supernatant of proliferating splenocytes. Additionally, therapeutic CsA treatment decreased the number of IFN-gamma-producing CD4(+) naive and memory T cells in the spleen. In contrast, behavioral conditioning increased that number. These data indicate that behavioral conditioning prolongs heart allograft survival by inhibiting the release of these cytokines in the spleen via sympathetic innervation, supplementing the inhibited cytokine production induced by CsA treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362751     DOI: 10.1152/ajpregu.1999.276.6.R1710

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

Review 1.  Behavioural conditioning as the mediator of placebo responses in the immune system.

Authors:  Sabine Vits; Elvir Cesko; Paul Enck; Uwe Hillen; Dirk Schadendorf; Manfred Schedlowski
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

2.  Expression of cytokines in acute heart transplantation rejection.

Authors:  Jiahong Xia; Lei Xu; Chenyuan Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

Review 3.  Psycho-Neuro-Endocrine-Immunological Basis of the Placebo Effect: Potential Applications beyond Pain Therapy.

Authors:  Ángel Ortega; Juan Salazar; Néstor Galban; Milagros Rojas; Daniela Ariza; Mervin Chávez-Castillo; Manuel Nava; Manuel E Riaño-Garzón; Edgar Alexis Díaz-Camargo; Oscar Medina-Ortiz; Valmore Bermúdez
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

4.  Treatment of experimental autoimmune encephalomyelitis with alpha lipoic acid and associative conditioning.

Authors:  Richard E Jones; Nicole Moes; Heather Zwickey; Christopher L Cunningham; William L Gregory; Barry Oken
Journal:  Brain Behav Immun       Date:  2007-12-26       Impact factor: 7.217

Review 5.  Learned immunosuppression: extinction, renewal, and the challenge of reconsolidation.

Authors:  Martin Hadamitzky; Harald Engler; Manfred Schedlowski
Journal:  J Neuroimmune Pharmacol       Date:  2012-07-13       Impact factor: 4.147

6.  Placebo effects on the immune response in humans: the role of learning and expectation.

Authors:  Antje Albring; Laura Wendt; Sven Benson; Oliver Witzke; Andreas Kribben; Harald Engler; Manfred Schedlowski
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

7.  Learned immunosuppressive placebo responses in renal transplant patients.

Authors:  Julia Kirchhof; Liubov Petrakova; Alexandra Brinkhoff; Sven Benson; Justine Schmidt; Maike Unteroberdörster; Benjamin Wilde; Ted J Kaptchuk; Oliver Witzke; Manfred Schedlowski
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-02       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.